Technical Analysis for TENX - Tenax Therapeutics, Inc.

Grade Last Price % Change Price Change
C 2.26 3.20% 0.07
TENX closed up 1.86 percent on Monday, March 1, 2021, on 2 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical TENX trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 1.04%
NR7 Range Contraction 1.04%
Inside Day Range Contraction 1.04%
Wide Bands Range Expansion 1.04%
Oversold Stochastic Weakness 1.04%
Stochastic Reached Oversold Weakness 2.92%
Wide Bands Range Expansion 2.92%
Oversold Stochastic Weakness 2.92%
Wide Bands Range Expansion -0.33%
Inside Day Range Contraction -3.38%
Older End-of-Day Signals for TENX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout 7 minutes ago
Up 2% about 2 hours ago
Up 1% about 2 hours ago
60 Minute Opening Range Breakout 1 day ago
Up 5% 1 day ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Tenax Therapeutics, Inc. Description

Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the development and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company also develops Oxycyte, a systemic perfluorocarbon product for use as oxygen carrier in the situations of acute ischemia; and a range of perfluorocarbon-based oxygen carriers for use in personal care, topical wound healing, and other topical indications. Its Oxycyte is under Phase II-b clinical trials for the treatment of traumatic brain injury. In addition, the company offers Dermacyte line of topical cosmetic products that promote the appearance of skin health and other cosmetic benefits; and Wundecyte, a wound-healing gel. It sells Dermacyte through distribution agreements, on-line retailers, and direct sales to physician and medical spa facilities. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Pharmaceutical Products Pharmacology Injury Wound Oxygen Healing Cardiac Surgery Ischemia Carbon Product Brain Injury Cosmetic Products Topical Medication Cardiac Output Traumatic Brain Injury Wound Healing

Is TENX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 3.68
52 Week Low 0.25
Average Volume 6,281,709
200-Day Moving Average 1.44
50-Day Moving Average 2.07
20-Day Moving Average 2.46
10-Day Moving Average 2.42
Average True Range 0.26
ADX 47.09
+DI 26.54
-DI 20.02
Chandelier Exit (Long, 3 ATRs ) 2.25
Chandelier Exit (Short, 3 ATRs ) 2.81
Upper Bollinger Band 2.89
Lower Bollinger Band 2.03
Percent B (%b) 0.18
BandWidth 34.86
MACD Line 0.03
MACD Signal Line 0.12
MACD Histogram -0.0875
Fundamentals Value
Market Cap 27.64 Million
Num Shares 12.6 Million
EPS -3.95
Price-to-Earnings (P/E) Ratio -0.56
Price-to-Sales 0.00
Price-to-Book 1.91
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.34
Resistance 3 (R3) 2.36 2.32 2.32
Resistance 2 (R2) 2.32 2.29 2.32 2.31
Resistance 1 (R1) 2.26 2.26 2.24 2.24 2.30
Pivot Point 2.22 2.22 2.22 2.22 2.22
Support 1 (S1) 2.16 2.19 2.14 2.14 2.08
Support 2 (S2) 2.12 2.16 2.12 2.07
Support 3 (S3) 2.06 2.12 2.07
Support 4 (S4) 2.04